Lesion therapy for Parkinson's disease and other movement disorders: update and controversies.
about
Clinical cases where lesion therapy was chosen over deep brain stimulationMotor thalamus integration of cortical, cerebellar and basal ganglia information: implications for normal and parkinsonian conditionsOptical measurements during experimental stereotactic radiofrequency lesioning.Surgical treatment of dyskinesia in Parkinson's disease.The striatofugal fiber system in primates: a reevaluation of its organization based on single-axon tracing studies.Deep brain stimulation alleviates parkinsonian bradykinesia by regularizing pallidal activityParkinson’s disease DBS: what, when, who and why? The time has come to tailor DBS targets.Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease.Relative contributions of local cell and passing fiber activation and silencing to changes in thalamic fidelity during deep brain stimulation and lesioning: a computational modeling study.Aphasia and thalamotomy: important issues.Safety considerations for deep brain stimulation: review and analysis.Parkinson's disease management strategies.Deep brain stimulation and the role of the neuropsychologist.Deep brain stimulation: indications and evidence.Reoperation for suboptimal outcomes after deep brain stimulation surgery.The role of deep brain stimulation in Parkinson's disease: an overview and update on new developments.Probing basal ganglia functions by saccade eye movements.Lesioning and stimulation in tremor-predominant movement disorder patients: an institutional case series and patient-reported outcome.Untangling Basal Ganglia Network Dynamics and Function: Role of Dopamine Depletion and Inhibition Investigated in a Spiking Network Model.High efficiency electrodes for deep brain stimulation.Voluntary saccade inhibition deficits correlate with extended white-matter cortico-basal atrophy in Huntington's disease.l-dopa-induced dyskinesias in unilateral 6-hydroxydopamine-lesioned rats are not modified by excitotoxic lesion of the entopeduncular nucleus and substantia nigra pars reticulata.The influence of intraoperative microelectrode recordings and clinical testing on the location of final stimulation sites in deep brain stimulation for Parkinson's disease.Discrepancies between the MRI- and the electrophysiologically defined subthalamic nucleus.Are complications less common in deep brain stimulation than in ablative procedures for movement disorders?Deep brain stimulation in Parkinson's disease: motor effects relative to the MRI-defined STN.Insights into Parkinson's disease from computational models of the basal ganglia.
P2860
Q28272394-5109D9C1-DACC-4165-80D4-5F8BDCA267D7Q28302667-1E38F1A1-BEC4-4299-8336-03BDA1EB81DFQ33250158-BEC53801-CEAA-4D21-8F52-822CB56FF1DDQ33569236-A7E49DA6-1BFD-441F-963B-CAF8887B1396Q33920107-5EE20897-2C03-4609-B5DA-48F04E304C76Q34108438-476A6A9B-AE52-4BC8-A00B-7611D733FD2CQ34795347-D3CF2B33-C59D-448C-9695-39A7B8625783Q35679727-20BF7935-662A-4AAE-A9EE-E01D9BE4AE36Q35783152-9EB99B96-394D-4655-A2F0-618457BBD3B5Q35959325-E769BBDC-1DC1-463D-BD44-BEF97CD479C9Q36315119-39913974-BA6C-45F8-8B69-F91F21FB540CQ36390875-39C85A05-B89A-474C-A2D9-20011D508131Q36762186-9A6BC84C-709C-4F89-A1FB-8E8061A1D296Q36938330-81DB2A0F-6E67-468C-AA87-9992E13A16FCQ37316474-F718C7BA-A2CA-453E-94EE-BBB6A165FDA0Q37698671-94BAEC20-4AA1-4E7C-85B2-D42B000E4A13Q37885421-02C8919B-A66D-41D4-B972-CBFF29FDDF77Q38017117-EC58F631-3B4A-4081-AD34-3F63E43184A6Q41431345-7C333813-A16D-4A46-9C7A-BFFDE261CD9BQ41953823-D81F7959-8C4A-4C23-8768-FCA2234CF42DQ42176734-F45EE9AA-89BF-49D3-BDFB-984F431D61E2Q42520633-A9495416-0EE8-47F7-B967-D57B96A527C0Q44764177-99515972-C87A-45AD-AABE-78E33D17CD90Q45272176-3440D91E-A618-42CE-9DC7-55ECC75009CFQ48491053-028855AB-F084-4AAC-9340-92D5D87F03E5Q50248119-5D34E297-7F7F-4CF5-863C-D9182ECBAA68Q52318709-8B2BF880-0D41-4D94-BCD6-D3872221D802
P2860
Lesion therapy for Parkinson's disease and other movement disorders: update and controversies.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Lesion therapy for Parkinson's ...... ers: update and controversies.
@ast
Lesion therapy for Parkinson's ...... ers: update and controversies.
@en
type
label
Lesion therapy for Parkinson's ...... ers: update and controversies.
@ast
Lesion therapy for Parkinson's ...... ers: update and controversies.
@en
prefLabel
Lesion therapy for Parkinson's ...... ers: update and controversies.
@ast
Lesion therapy for Parkinson's ...... ers: update and controversies.
@en
P2860
P356
P1433
P1476
Lesion therapy for Parkinson's ...... ers: update and controversies.
@en
P2093
Jerrold L Vitek
Michael S Okun
P2860
P304
P356
10.1002/MDS.20037
P407
P577
2004-04-01T00:00:00Z